This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Vitae Pharmaceuticals, Inc.. Active years: 2014-2024.
Location History:
- Eberhardzell-Dietenwegen, DE (2014)
- Eberhardzell-Dietenwengen, DE (2016 - 2024)
Company Filing History:
7 out of 1,560 
1 out of 85 
Years Active: 2014-2024
Title: The Innovative Contributions of Martin Renz
Introduction
Martin Renz is a notable inventor based in Eberhardzell-Dietenwengen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of DPP-IV inhibitors. With a total of 7 patents to his name, Renz has established himself as a key figure in innovation.
Latest Patents
Among his latest patents, Renz has focused on polymorphous crystal modifications of a DPP-IV inhibitor. His inventions relate to the preparation and use of these polymorphs for creating effective medicaments. This work highlights his commitment to advancing medical science and improving therapeutic options.
Career Highlights
Throughout his career, Martin Renz has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Vitae Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities.
Collaborations
Renz has collaborated with several professionals in his field, including Peter Sieger and Dirk Kemmer. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Martin Renz's contributions to the field of pharmaceuticals through his innovative patents and collaborations demonstrate his significant impact on medical advancements. His work continues to influence the development of new treatments and therapies.